These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 11144928)
1. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341 [TBL] [Abstract][Full Text] [Related]
3. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Yin H; Leong AS Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208 [TBL] [Abstract][Full Text] [Related]
4. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder. Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527 [TBL] [Abstract][Full Text] [Related]
6. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Holmäng S; Johansson SL Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355 [TBL] [Abstract][Full Text] [Related]
7. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Samaratunga H; Khoo K Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Gonul II; Poyraz A; Unsal C; Acar C; Alkibay T Urol Int; 2007; 78(4):338-44. PubMed ID: 17495493 [TBL] [Abstract][Full Text] [Related]
9. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression. Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881 [TBL] [Abstract][Full Text] [Related]
10. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. Barbisan F; Santinelli A; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M; van der Kwast T; Montironi R Cancer; 2008 Feb; 112(3):636-44. PubMed ID: 18072261 [TBL] [Abstract][Full Text] [Related]
11. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Curry JL; Wojcik EM Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301 [TBL] [Abstract][Full Text] [Related]
12. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases. McKenney JK; Amin MB; Young RH Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056 [TBL] [Abstract][Full Text] [Related]
13. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722 [TBL] [Abstract][Full Text] [Related]
14. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Lee TK; Chaux A; Karram S; Miyamoto H; Miller JS; Fajardo DA; Epstein JI; Netto GJ Hum Pathol; 2011 Nov; 42(11):1799-803. PubMed ID: 21777949 [TBL] [Abstract][Full Text] [Related]
15. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998. Mamoon N; Iqbal MA; Jamal S; Luqman M J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804 [TBL] [Abstract][Full Text] [Related]
16. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Harnden P; Mahmood N; Southgate J Lancet; 1999 Mar; 353(9157):974-7. PubMed ID: 10459907 [TBL] [Abstract][Full Text] [Related]
17. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945 [TBL] [Abstract][Full Text] [Related]
18. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Inman BA; Sebo TJ; Frigola X; Dong H; Bergstralh EJ; Frank I; Fradet Y; Lacombe L; Kwon ED Cancer; 2007 Apr; 109(8):1499-505. PubMed ID: 17340590 [TBL] [Abstract][Full Text] [Related]
19. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression. Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523 [TBL] [Abstract][Full Text] [Related]
20. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification. Whisnant RE; Bastacky SI; Ohori NP Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]